-
Pre-metastatic niche: formation, characteristics and therapeutic implication Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-25 Yuhang Wang, Jiachi Jia, Fuqi Wang, Yingshuai Fang, Yabing Yang, Quanbo Zhou, Weitang Yuan, Xiaoming Gu, Junhong Hu, Shuaixi Yang
-
Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-09-25 Edo Kapetanovic, Cédric R. Weber, Marine Bruand, Daniel Pöschl, Jakub Kucharczyk, Elisabeth Hirth, Claudius Dietsche, Riyaz Khan, Bastian Wagner, Olivier Belli, Rodrigo Vazquez-Lombardi, Rocío Castellanos- Rueda, Raphael B. Di Roberto, Kevin Kalinka, Luca Raess, Kevin Ly, Shivam Rai, Petra S. Dittrich, Randall J. Platt, Elisa Oricchio, Sai T. Reddy
-
Understanding genetics, sex and signaling: Implications of sex-dependent APOE4-neutrophil-microglia interactions for Alzheimer’s and tauopathies Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-23 Natja Haag, Juliane Bremer, Hans Zempel
-
Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-23 Marc A. Weniger, Ralf Küppers
-
Spliceosomal repression: unleashing human cell totipotency Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-23 Felipe F. Lüttmann, Kee-Pyo Kim, Johnny Kim
-
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-23 Ziqi Ma, Tao Zuo, Norbert Frey, Ashraf Yusuf Rangrez
-
Single-cell exome sequencing reveals polyclonal seeding and TRPS1 mutations in colon cancer metastasis Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-23 Jianqiang Cai, Weilong Zhang, Yalan Lu, Wenjie Liu, Haitao Zhou, Mei Liu, Xinyu Bi, Jianmei Liu, Jinghua Chen, Yanjiang Yin, Yiqiao Deng, Zhiwen Luo, Yi Yang, Qichen Chen, Xiao Chen, Zheng Xu, Yueyang Zhang, Chaoling Wu, Qizhao Long, Chunyuan Huang, Changjian Yan, Yan Liu, Lei Guo, Weihua Li, Pei Yuan, Yucheng Jiao, Wei Song, Xiaobing Wang, Zhen Huang, Jianming Ying, Hong Zhao
-
Neutrophil extracellular traps in homeostasis and disease Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-20 Han Wang, Susan J. Kim, Yu Lei, Shuhui Wang, Hui Wang, Hai Huang, Hongji Zhang, Allan Tsung
-
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-20 Yifan Liu, Renjie Pan, Yuzhen Ouyang, Wangning Gu, Tengfei Xiao, Hongmin Yang, Ling Tang, Hui Wang, Bo Xiang, Pan Chen
-
Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood–brain barrier Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-09-20 James G. Shamul, Zhiyuan Wang, Hyeyeon Gong, Wenquan Ou, Alisa M. White, Diogo P. Moniz-Garcia, Shuo Gu, Alisa Morss Clyne, Alfredo Quiñones-Hinojosa, Xiaoming He
-
Allergic reactions to horse chestnut seeds are caused by mugwort pollen art v 1‐sensitization and represent a novel type of defensin‐related allergy syndrome Allergy (IF 12.6) Pub Date : 2024-09-24 Valentina Cosi, Sabrina Wildner, Christine Kapfhammer, Stephanie Eichhorn, Peter Briza, Wolfgang Hemmer, Gabriele Gadermaier
-
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-23 Anna J Podolanczuk,Sara Tomassetti
-
Don't Just Look East (the Other Way) When There's Smoke Billowing to the West. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-23 Laura C Myers,Nina Pak,Eric Balaban,Neeta Thakur,Kevin Cromar
-
Virtual Peer Support for ICU Survivors Is Feasible, and May Improve Outcomes for ICU Survivors: Results from the icuRESOLVE-D (icu Recovery Solutions Co-Designed through SurVivor Engagement - Digital) Pilot Randomised Controlled Trial. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-23 Nina Leggett,Yasmine Ali Abdelhamid,Erin Bicknell,Sarah Booth,Jacki Carmody,Adam M Deane,K J Farley,Amalia Karahalios,Mark Merolli,Kimberley J Haines
-
Validation of Systemic Complement Signatures in the Progression of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-23 Katarina M DiLillo,Lisa Ruvuna,Katherine A Pratte,Karina A Serban,Wassim W Labaki,MeiLan K Han,Christine M Freeman,Russell P Bowler,Jeffrey L Curtis,Kelly B Arnold,
-
Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-23 Meghan D Althoff,Kristina Gaietto,Fernando Holguin,Erick Forno
Though obesity-related asthma associated with worse asthma outcomes, optimal treatment approaches for this complex phenotype are still largely unavailable. This state-of-the-art review article synthesizes evidence for existing and emerging treatment approaches for obesity-related asthma and highlights pathways that offer potential targets for novel therapeutics. Existing treatments targeting insulin
-
Defining Interstitial Lung Disease Progression: It Is Time to (Get Our) Act Together. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-23 Vanessa Smith,Maurizio Cutolo,Elizabeth Volkmann
-
Cross‐protection of AIT‐induced antibodies to related allergens requires a high degree of structural identity Allergy (IF 12.6) Pub Date : 2024-09-23 Hilal Demir, Christian Radauer, Maria R. Strobl, Stephan Scheurer, Tamar Kinaciyan, Barbara Bohle
BackgroundIn contrast to sublingual immunotherapy (SLIT) with recombinant Mal d 1 (rMal d 1‐SLIT), SLIT with rBet v 1 (rBet v 1‐SLIT) induced Mal d 1‐cross‐reactive antibodies without IgE‐blocking activity. To elucidate whether the development of cross‐protective IgG responses depends on the degree of molecular identity of allergens we compared the cross‐reactivity, cross‐blocking activity, and affinity
-
A novel cytoprotective organ perfusion platform for reconstructing homeostasis of DCD liver while alleviating IRI injury Bioeng. Transl. Med. (IF 6.1) Pub Date : 2024-09-23 Tingting Lan, Mingxing Yu, Tao Ming, Hong Wang, Juan Deng, Shuhan Cheng, Zhongyang Shen, Deling Kong
Pump is a vital component for expelling the perfusate in small animal isolated organ normothermic machine perfusion (NMP) systems whose flexible structure and rhythmic contraction play a crucial role in maintaining perfusion system homeostasis. However, the continuous extrusion forming with the rigid stationary shaft of the peristaltic pumps can damage cells, leading to metabolic disorders and eventual
-
Low mannose‐binding lectin levels is associated with aspirin unresponsiveness in aspirin‐exacerbated respiratory disease Allergy (IF 12.6) Pub Date : 2024-09-22 Blanka Kaplan, Nikki Kimura, Joanna S. Fishbein, Pinky Varghese, Margherita Bruni, Judd Fastenberg, Janice Wang
-
Comparison of social network engagement performance between artificial intelligence‐generated content and human experts: A study in the field of immunology and allergology Allergy (IF 12.6) Pub Date : 2024-09-22 Stefano Palazzo, Cataldo Piarulli, Francesca Lerario, Marco Cinquantasei, Marcello Albanesi
-
Privacy-preserving large language models for structured medical information retrieval npj Digit. Med. (IF 12.4) Pub Date : 2024-09-20 Isabella Catharina Wiest, Dyke Ferber, Jiefu Zhu, Marko van Treeck, Sonja K. Meyer, Radhika Juglan, Zunamys I. Carrero, Daniel Paech, Jens Kleesiek, Matthias P. Ebert, Daniel Truhn, Jakob Nikolas Kather
-
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update Allergy (IF 12.6) Pub Date : 2024-09-20 Alexandra F. Santos, Carmen Riggioni, George Du Toit, Isabel Skypala
-
Approval of the first TCR-based cell therapy. Mol. Ther. (IF 12.1) Pub Date : 2024-09-20 Nathan Singh
-
Zero shot health trajectory prediction using transformer npj Digit. Med. (IF 12.4) Pub Date : 2024-09-19 Pawel Renc, Yugang Jia, Anthony E. Samir, Jaroslaw Was, Quanzheng Li, David W. Bates, Arkadiusz Sitek
-
Regulatory responses and approval status of artificial intelligence medical devices with a focus on China npj Digit. Med. (IF 12.4) Pub Date : 2024-09-18 Yuehua Liu, Wenjin Yu, Tharam Dillon
-
Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-19 Jiujie Cui, Shukui Qin, Yuhong Zhou, Shuang Zhang, Xiaofeng Sun, Mingjun Zhang, Jiuwei Cui, Weijia Fang, Kangsheng Gu, Zhihua Li, Jufeng Wang, Xiaobing Chen, Jun Yao, Jun Zhou, Gang Wang, Yuxian Bai, Juxiang Xiao, Wensheng Qiu, Bangmao Wang, Tao Xia, Chunyue Wang, Li Kong, Jiajun Yin, Tao Zhang, Xionghu Shen, Deliang Fu, Chuntao Gao, Huan Wang, Quanren Wang, Liwei Wang
-
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-19 Qiaonan Shan, Lu Yin, Qifan Zhan, Jiongjie Yu, Sheng Pan, Jianyong Zhuo, Wei Zhou, Jiaqi Bao, Lincheng Zhang, Jiachen Hong, Jianan Xiang, Qingyang Que, Kangchen Chen, Shengjun Xu, Jingrui Wang, Yangbo Zhu, Bin He, Jingbang Wu, Haiyang Xie, Shusen Zheng, Tingting Feng, Sunbin Ling, Xiao Xu
-
Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology Allergy (IF 12.6) Pub Date : 2024-09-19 Romane Cadot, Perrine Gery, Vanina Lenief, Jean‐François Nicolas, Marc Vocanson, Marie Tauber
Severe cutaneous adverse reactions to drugs (SCARs) are rare but life‐threatening delayed allergies. While they primarily affect the skin, they can also affect internal organs. Accordingly, they present with diverse clinical symptoms that vary not only between SCARs subtypes but also among patients. Despite the availability of topical and systemic treatments, these only address the symptoms and not
-
Sirens and sphingolipids: What lures hematopoietic stem cells to the nervous system? Mol. Ther. (IF 12.1) Pub Date : 2024-09-19 Yedda Li,Florian S Eichler
-
Tumor-intrinsic kinase: A promising target for overcoming resistance to immune checkpoint blockade therapies. Mol. Ther. (IF 12.1) Pub Date : 2024-09-19 Jianhui Wang,Gaowei Xia,Bin Meng,Xingang Guan
-
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-18 Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao
-
Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2 Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-18 Miao Zhu, Fang Huang, Huize Sun, Kunpeng Liu, Zhen Chen, Baocheng Yu, Haojie Hao, Haizhou Liu, Shuang Ding, Xueyan Zhang, Lishi Liu, Kui Zhang, Jierao Ren, Yi Liu, Haibin Liu, Chao Shan, Wuxiang Guan
-
HLA‐DR+ regulatory T cells and IL‐10 are associated with success or failure of desensitization outcomes Allergy (IF 12.6) Pub Date : 2024-09-18 Xiaoying Zhou, Diane Dunham, Sayantani B. Sindher, Andrew Long, Andrea Fernandes, Iris Chang, Amal Assa'ad, Jacqueline Pongracic, Jonathan M. Spergel, Jonathan Tam, Stephen Tilles, Julie Wang, Scott D. Boyd, R. Sharon Chinthrajah, Kari C. Nadeau
BackgroundOmalizumab (XOLAIR®)‐assisted multi‐food oral immunotherapy (mOIT) has been shown to safely, effectively, and rapidly desensitize patients with multiple food allergies. In our clinical trial (NCT02626611) on omalizumab‐assisted mOIT, different desensitization outcomes (success or failure of desensitization) were observed following a period of either continued or discontinued mOIT. However
-
A drug mix and dose decision algorithm for individualized type 2 diabetes management npj Digit. Med. (IF 12.4) Pub Date : 2024-09-17 Mila Nambiar, Yong Mong Bee, Yu En Chan, Ivan Ho Mien, Feri Guretno, David Carmody, Phong Ching Lee, Sing Yi Chia, Nur Nasyitah Mohamed Salim, Pavitra Krishnaswamy
-
A systematic review and meta analysis on digital mental health interventions in inpatient settings npj Digit. Med. (IF 12.4) Pub Date : 2024-09-17 Alexander Diel, Isabel Carolin Schröter, Anna-Lena Frewer, Christoph Jansen, Anita Robitzsch, Gertraud Gradl-Dietsch, Martin Teufel, Alexander Bäuerle
-
How might Hospital at Home enable a greener and healthier future? npj Digit. Med. (IF 12.4) Pub Date : 2024-09-16 Dylan Powell, Fanny Burrows, Geraint Lewis, Stephen Gilbert
-
Recurrent Pulmonary Veno-Occlusive Disease after Lung Transplantation. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-17 Esther J Nossent,Gregorius D Nossent,Lilian J Meijboom,Erik A M Verschuuren,Chistiaan T Gan,Jurjan Aman,Harm Jan Bogaard,Teodora Radonic,Peter Dorfmüller,Anton Vonk Noordegraaf
-
Lung Protective Mechanical Ventilation in Severe Acute Brain Injured Patients: A Multicenter, Randomized Clinical Trial (PROLABI). Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-17 Luciana Mascia,Vito Fanelli,Alice Mistretta,Matteo Filippini,Mattia Zanin,Maurizio Berardino,Anna Teresa Mazzeo,Anselmo Caricato,Massimo Antonelli,Francesco Della Corte,Francesca Grossi,Marina Munari,Massimiliano Caravello,Francesco Alessandri,Irene Cavalli,Mario Mezzapesa,Lucia Silvestri,Marilena Casartelli Liviero,Paolo Zanatta,Paolo Pelosi,Giuseppe Citerio,Claudia Filippini,Paola Rucci,Frank A Rasulo
BACKGROUND Lung protective strategies using low tidal volumes and moderate positive end expiratory pressures (PEEP) are considered best practice in critical care, but interventional trials have never been conducted in acutely brain-injured patients due to concerns about carbon dioxide control and effect of PEEP on cerebral hemodynamic. METHODS In this multicenter, open-label, controlled clinical trial
-
Up‐dosing of reslizumab in severe asthmatics with persistent sputum eosinophilia: A feasibility study Allergy (IF 12.6) Pub Date : 2024-09-17 Manali Mukherjee, Jaime Bernaola, Santi Nolasco, Melanie Kjarsgaard, Yinglan Xie, Katherine Radford, Bashayr Alotaibi, Carmen Venegas Garrido, Parameswaran Nair
-
Synergistic Integration of mRNA-LNP with CAR-Engineered Immune Cells: Pioneering Progress in Immunotherapy. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Zhaozhao Chen,Jinhui Shu,Yu Hu,Heng Mei
Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a revolutionary approach in the treatment of malignancies. Despite its remarkable successes, this field continues to grapple with challenges such as scalability, safety concerns, limited therapeutic effect, in vivo persistence, and the need for precise control over CAR expression. In the post-pandemic era of COVID-19 vaccine immunization
-
Therapeutic CRISPR Epigenome Editing of Inflammatory Receptors in the Intervertebral Disc. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Joshua D Stover,Matthew A R Trone,Jacob Weston,Christian Lewis,Hunter Levis,Niloofar Farhang,Matthew Philippi,Michelle Zeidan,Brandon Lawrence,Robby D Bowles
Low back pain (LBP) ranks among the leading causes of disability worldwide and generates a tremendous socioeconomic cost. Disc degeneration, a leading contributor to LBP, can be characterized by the breakdown of the extracellular matrix of the intervertebral disc (IVD), disc height loss, and inflammation. The inflammatory cytokine TNF-α has multiple signaling pathways, including proinflammatory signaling
-
Hypermethylation and downregulation of microRNA219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Qingqing Wei,Xiao Xiao,Emily Huo,Chunyuan Guo,Xiangjun Zhou,Xiaoru Hu,Charles Dong,Huidong Shi,Zheng Dong
Epigenetic regulations, such as DNA methylation and microRNAs, play an important role in renal fibrosis. Here, we report the regulation of microRNA-219a-2 by DNA methylation in fibrotic kidneys, unveiling the crosstalk between these epigenetic mechanisms. Through genome-wide DNA methylation analysis and pyro-sequencing, we detected the hypermethylation of microRNA219a-2 in renal fibrosis induced by
-
Intranasal vaccination with engineered BCG expressing CCL2 induces a stronger immune barrier against Mycobacterium tuberculosis than BCG. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Shaohua Guo,Jiangshan Ouyang,Zhiming Hu,Ting Cao,Chunxu Huang,Jun Mou,Xinxia Gu,Jie Liu
Intradermal Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccination is currently the only licensed strategy for preventing tuberculosis (TB). It provides limited protection against pulmonary TB. To enhance the efficacy of BCG, we developed a recombinant BCG expressing exogenous monocyte chemoattractant CC chemokine ligand 2 (CCL2), termed rBCG-CCL2. Co-culturing macrophages with rBCG-CCL2 enhances
-
Toward life without sickle cell disease. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Utpal P Davé,Jörg Bungert
-
Immune responses to cells and proteins after hematopoietic stem cell gene therapy for inherited diseases: A cause for concern. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Nathan Jeffreys,Robert Wynn
-
-
VSTM2A reverses immunosuppression in colorectal cancer through antagonizing PD-L1/PD-1 interaction. Mol. Ther. (IF 12.1) Pub Date : 2024-09-17 Yujuan Dong,Jiaxun Jade Liu,Yunfei Zhou,Wei Kang,Shanglin Li,Alvin Hk Cheung,Hu Yi,Rui Liao,Nathalie Wong,Chi Chun Wong,Simon Ng,Jun Yu
Immunoglobulin VSTM2A is a top-ranked secretory protein that frequently silenced during colorectal carcinogenesis, however, its role in immune modulation remains largely unknown. Bioinformatic and immunohistochemistry analysis of human colorectal specimens and Vstm2a+/- knockout mice indicated that VSTM2A positively correlated with CD8a and immune infiltration in both physiological and pathological
-
Macrophages overexpressing interleukin‐10 target and prevent atherosclerosis: Regression of plaque formation and reduction in necrotic core Bioeng. Transl. Med. (IF 6.1) Pub Date : 2024-09-17 Mingyi Wang, Shanshan Zhou, Yingyun Hu, Wei Tong, Hao Zhou, Mingrui Ma, Xingxuan Cai, Zhengbin Zhang, Luo Zhang, Yundai Chen
Atherosclerosis, a slowly progressing inflammatory disease, is characterized by the presence of monocyte‐derived macrophages. Interventions targeting the inflammatory characteristics of atherosclerosis hold promising potential. Although interleukin (IL)‐10 is widely acknowledged for its anti‐inflammatory effects, systemic administration of IL‐10 has limitations due to its short half‐life and significant
-
The case for inclusive co-creation in digital health innovation npj Digit. Med. (IF 12.4) Pub Date : 2024-09-16 Grace C. Nickel, Serena Wang, Jethro C. C. Kwong, Joseph C. Kvedar
This piece critiques the exclusion of healthcare practitioners (HCPs) from the digital health innovation process. Drawing on “Sync fast and solve things—best practices for responsible digital health” by Landers et al., the editorial argues for the importance of inclusive co-creation, in which clinicians play an active role in developing digital health solutions. It emphasizes that without the meaningful
-
Deep behavioural representation learning reveals risk profiles for malignant ventricular arrhythmias npj Digit. Med. (IF 12.4) Pub Date : 2024-09-16 Maarten Z. H. Kolk, Diana My Frodi, Joss Langford, Tariq O. Andersen, Peter Karl Jacobsen, Niels Risum, Hanno L. Tan, Jesper Hastrup Svendsen, Reinoud E. Knops, Søren Zöga Diederichsen, Fleur V. Y. Tjong
-
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-16 Xiao Han, Jun Guo, Lingyu Li, Yong Huang, Xue Meng, Linlin Wang, Hui Zhu, Xiangjiao Meng, Qian Shao, Xing Li, Yan Zhang, Jin Wang, Yanhua Chen, Yingjie Zhang, Yiru Chen, Changbin Zhu, Zhehai Wang
-
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases Signal Transduct. Target Ther. (IF 40.8) Pub Date : 2024-09-16 Weiyi Yao, Xinting Hu, Xin Wang
-
Non-viral targeted insertion of large payloads into T cells Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-09-16 Zsuzsanna Izsvák
-
Unraveling the Complexities of Mesenchymal Stromal Cell-based Therapies: One Size Doesn't Fit All. Am. J. Respir. Crit. Care Med. (IF 19.3) Pub Date : 2024-09-15 Daniel J Weiss
-
A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder npj Digit. Med. (IF 12.4) Pub Date : 2024-09-14 Andrew Quanbeck, Ming-Yuan Chih, Linda Park, Xiang Li, Qiang Xie, Alice Pulvermacher, Samantha Voelker, Rachel Lundwall, Katherine Eby, Bruce Barrett, Randall Brown
-
Variational Bayes machine learning for risk adjustment of general outcome indicators with examples in urology npj Digit. Med. (IF 12.4) Pub Date : 2024-09-14 Harvey Jia Wei Koh, Dragan Gašević, David Rankin, Stephane Heritier, Mark Frydenberg, Stella Talic
-
Results and implications for generative AI in a large introductory biomedical and health informatics course npj Digit. Med. (IF 12.4) Pub Date : 2024-09-13 William Hersh, Kate Fultz Hollis
-
Long-term changes in wearable sensor data in people with and without Long Covid npj Digit. Med. (IF 12.4) Pub Date : 2024-09-13 Jennifer M. Radin, Julia Moore Vogel, Felipe Delgado, Erin Coughlin, Matteo Gadaleta, Jay A. Pandit, Steven R. Steinhubl
-
Can social media encourage diabetes self-screenings? A randomized controlled trial with Indonesian Facebook users npj Digit. Med. (IF 12.4) Pub Date : 2024-09-13 Manuela Fritz, Michael Grimm, Ingmar Weber, Elad Yom-Tov, Benedictus Praditya